Skip to search formSkip to main contentSkip to account menu

Pindolol Oral Tablet [Visken]

National Institutes of Health

Related topics

Related topics

3 relations
Oral TabletVisken

Narrower (1)

Pindolol 10 MG Oral Tablet [Visken]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Using single-isomer octa(6-O-sulfo)-γ-cyclodextrin for fast capillary zone electrophoretic enantioseparation of pindolol: Determination of complexation constants, software-assisted optimization, and…
2004
2004
Combination therapy of essential hypertension with pindolol (Visken) and hydralazine
SummaryThirty patients suffering from essential hypertension were treated successively with placebo, hydralazine alone, and… 
1993
1993
Subject index
1981
1981
Subject Index
A9-dopaminergic phenotype, 2083 Active caspase 3, 1381 Acute kidney injury (AKI), 517 Acute liver failure after massive… 
1976
1976
Die Beeinflussung der funktionellen Eigenschaften des menschlichen Erregungsleitungssystems durch Frequenzbelastung, elektroinduzierte Vorhofextrasystolen und Blockade des autonomen Nervensystems…
Summary32 patients were studied by His-bundle-electrocardiogram and programmed atrial stimulation to examine to which extent… 
1975
1975
[Controlled study of high blood pressure treatment using betablocker Visken (author's transl)].
1973
1973
Treatment of hypertension with a new beta-blocking agent, pindolol (Visken®)
SummaryForty patients with essential hypertension were treated with a new beta-blocking agent, 4-2 (2-hydroxy-3-isopropyl-amino… 
1973
1973
The effect of 1-(Indol-4-yl-oxy)-3-isopropylamino-propan-2-ol (LB-46, Visken) on carbohydrate and lipid metabolism
SummaryThe effect of i.v. LB-46 (Visken®), 0.6 mg, on blood concentrations of various parameters of carbohydrate (blood sugar… 
1972
1972
A double blind study of Visken LB-46, in the treatment of angina pectoris.
1972
1972
A double blind study of Visken LB-46, in the treatment of angina pectoris.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)